Neurocognitive Risks in Children With Solid Tumors
NCT03609112 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2024-12-13
Summary
The survival rate of children with cancer has improved significantly in recent years thanks to the progress of different therapies. The neurocognitive sequelae related to treatments and illness are more or less well known. Four factors seem to be associated with neurocognitive sequelae: treatment, the tumor itself, environmental factors like the socio-economic status of parents and biological factors.
Main purpose of the study is to establish a score to assess the risk of neurocognitive sequelae in these children based on these factors (treatment, tumor, and environmental factors)
Conditions
- Solid Tumor in Children
Interventions
- OTHER
-
The WISC-V
The WISC-V (Weschler, 2016) which is measured with several indices: Verbal Comprehension Index (VCI), Visual Spatial Index (VSI), Working Memory Index (WMI), Fluid Reasoning Index (FRI), Processing Speed Index (PSI), and Full Scale IS (FSIQ).
- OTHER
-
The NEPSY-II
The NEPSY-II (Korkman et al., 2012). The Narrative Memory subtest is designed to assess verbal memory using organised language material.
- OTHER
-
The Child Executive Function Evaluation Battery CEF
The Child Executive Function Evaluation Battery CEF (Roy et al., 2021), which aims to evaluate the four main components of executive function (inhibition, working memory, flexibility and planning).
- OTHER
-
The "CONNERS 3 long version"
The " CONNERS 3 long version " (Conners, 2008), which assesses attentional skills by means of a questionnaire to be completed by parents.
- OTHER
-
The "BRIEF"
The 'BRIEF' (Gioia et al., 2013; parent version, teacher version), which is a behavioural evaluation inventory of executive functions completed by parents and teachers and which makes it possible to determine whether the child has, for example, difficulties with organisation, planning or behavioural regulation.
- OTHER
-
The "PEDS-QL quality of life"
The "PEDS-QL quality of life" (Tessier et al., 2009) that will be completed by the parents and the patient concerns the day to- day functioning of the child (in school, relationships to others, physical abilities and emotional state).
- OTHER
-
The 'fatigue' version of the PEDS-QL (Tessier et al., 2009: parent and child-adolescent version for the brain tumour cohort)
The 'fatigue' version of the PEDS-QL (Tessier et al., 2009: parent and child-adolescent version for the brain tumour cohort) which assesses fatigue in everyday life.
- OTHER
-
The Family Functioning Inventory FAD)
The Family Functioning Inventory FAD (Speranza et al., 2006) is used to assess the family functioning of the child and his/her family. The short version is used as an indicator of general functioning.
- OTHER
-
The 'fatigue' version of the PEDS-QL (Tessier et al., 2009: child version for the extra-cerebral tumour cohort)
The 'fatigue' version of the PEDS-QL (Tessier et al., 2009: child version for the extra-cerebral tumour cohort) which assesses fatigue in everyday life.
Sponsors & Collaborators
-
Gustave Roussy, Cancer Campus, Grand Paris
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-01
- Primary Completion
- 2025-09-30
- Completion
- 2025-09-30
Countries
- France
Study Locations
More Related Trials
-
Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years
NCT00936156 ·Status: COMPLETED ·Phase: PHASE2
-
KEYS to Succeed: Cognitive and Academic Intervention Program for Children and Adolescents Surviving Cancer
NCT02573441 ·Status: COMPLETED ·Phase: NA
-
Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain Tumors
NCT01342237 ·Status: UNKNOWN ·Phase: PHASE2
-
Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor
NCT00004068 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents
NCT01535183 ·Status: UNKNOWN ·Phase: PHASE2
-
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors
NCT00001574 ·Status: COMPLETED
-
A Pilot Study to Examine Sleep and Fatigue in Pediatric Brain Tumor Patients Hospitalized for High Dose Chemotherapy
NCT00666614 ·Status: COMPLETED ·Phase: NA
-
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
NCT00002485 ·Status: COMPLETED
-
Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas
NCT01574092 ·Status: COMPLETED ·Phase: PHASE2
-
Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
NCT00360945 ·Status: UNKNOWN ·Phase: PHASE2
-
Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma
NCT00602667 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors
NCT00003096 ·Status: COMPLETED
-
Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma
NCT00418327 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
NCT00281905 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents
NCT00147160 ·Status: COMPLETED ·Phase: PHASE2
-
High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors
NCT00798811 ·Status: UNKNOWN ·Phase: PHASE2
-
Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS
NCT00003859 ·Status: COMPLETED ·Phase: PHASE3
-
Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
NCT00683319 ·Status: ACTIVE_NOT_RECRUITING
-
Study of @neWorld: A Virtual Community for Children With Cancer
NCT00070421 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Impact of Chemotherapy on Memory Function and the Development of Traumatic Symptoms in Children With Cancer
NCT01108952 ·Status: UNKNOWN
-
Intensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT)
NCT07338526 ·Status: RECRUITING ·Phase: NA
-
Irinotecan in Treating Children With Refractory Solid Tumors
NCT00004078 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma
NCT00024336 ·Status: UNKNOWN ·Phase: PHASE2
-
Learning Impairments Among Survivors of Childhood Cancer
NCT00576472 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
NCT06942039 ·Status: RECRUITING ·Phase: EARLY_PHASE1